Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

No reported Short-term Debt figures are available to summarize.

Short-term Debt history

Currency unavailable · from the balance sheet

No Short-term Debt data reported for this period type.

Short-term Debt vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Short-term Debt for LTGO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SCLXScilex Holding CompanyMar 2026$88.07M USD+123.3%—30.0%
COLLCollegium Pharmaceutical, Inc.Mar 2026$34.07M USD-47.2%-42.8%2.1%
PCRXPacira BioSciences, Inc.Mar 2026$9.82M USD-95.1%-33.6%0.8%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —-47.2%-38.2%2.1%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.